Imatinib mesylate 400 mg

DRUG2 trials

Sponsors

Poitiers University Hospital

Conditions

Chronic Myeloid Leukemia

Phase 2

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

CompletedNCT00219752

Poitiers University HospitalChronic Myeloid Leukemia

Start: 2002-05-31End: 2007-05-31Target: 30Updated: 2005-12-22

Phase 3

STI571 ProspectIve RandomIzed Trial: SPIRIT

CompletedNCT00219739

Poitiers University HospitalChronic Myeloid Leukemia

Start: 2003-09-30End: 2014-12-31Updated: 2020-04-13

Related Papers

Molecular landscape and clonal evolution in minor versus major BCR::ABL1 chronic myeloid leukemia under tyrosine kinase inhibition : A Study from the french group fi-LMC

Blood2025-11-03

Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.

2010-12-01268 citations